Status:
COMPLETED
HBV Envelope Proteins Variability on HBs Antigen Clearance Under Nucleos(t)Ide Analogue Therapy
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Hepatitis B, Chronic
Eligibility:
All Genders
18+ years
Brief Summary
Hepatitis B virus (HBV) infection remains difficult to eradicate with about 240 million people living with HBV chronic infection. HBsAg clearance, correlated with a good clinical prognosis, is difficu...
Detailed Description
Our study is a retrospective study of patients with chronic hepatitis B virus, selected exclusively at the University Hospital Center of Nancy in the Department of Hepato-Gastroenterology (HGE). the p...
Eligibility Criteria
Inclusion
- adults
- patients with chronic hepatitis B
- treated with nucleos(t)ide analogues
- mono-infected with HBV (without co-infection with HCV, HIV and HDV)
Exclusion
- minor
- pregnant women
- patients with VHC or VHD
Key Trial Info
Start Date :
November 5 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2017
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT03350074
Start Date
November 5 2013
End Date
September 1 2017
Last Update
November 22 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.